Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 84,052 | 80,248 | 75,400 | 70,502 | 70,162 |
| Cost of Goods | 330 | 448 | 1,707 | 246 | 199 |
| Gross Profit | 83,722 | 79,800 | 73,693 | 70,256 | 69,963 |
| Operating Expenses | 103,504 | 88,750 | 90,417 | 96,992 | 87,214 |
| Operating Income | -19,452 | -8,502 | -16,017 | -26,490 | -17,052 |
| Interest Expense | 7,038 | 4,290 | 4,277 | 3,239 | 1,309 |
| Other Income | 1,669 | 18,885 | 10,164 | 5,650 | -7,281 |
| Pre-tax Income | -24,821 | 6,093 | -10,130 | -24,079 | -25,642 |
| Income Tax | -1,050 | -2,643 | 1,486 | 357 | -5,912 |
| Net Income Continuous | -23,771 | 8,736 | -11,616 | -24,436 | -19,730 |
| Net Income | $-23,771 | $8,736 | $-11,616 | $-24,436 | $-19,730 |
| EPS Basic Total Ops | -0.47 | 0.17 | -0.23 | -0.49 | -0.40 |
| EPS Basic Continuous Ops | -0.47 | 0.17 | -0.23 | -0.49 | -0.40 |
| EPS Diluted Total Ops | -0.47 | 0.17 | -0.23 | -0.49 | -0.40 |
| EPS Diluted Continuous Ops | -0.47 | 0.17 | -0.23 | -0.49 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.47 | 0.17 | -0.23 | N/A | N/A |
| EBITDA(a) | $-18,286 | $-7,467 | $-15,025 | $-25,479 | $-16,020 |